Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Haber

Showing results (271-280 of 303) with videos related to

Pageof 31
Sort By:
Neurology|November 13, 2002
Cognitive impairments in advanced PD without dementiaJ Green, W M McDonald, J L Vitek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2000
MYCN expression is not prognostic of adverse outcome in advanced-stage neuroblastoma with nonamplified MYCNS L Cohn, W B London, D Huang, et al.
Biochimica Et Biophysica Acta. Gene Regulatory Mechanisms|November 3, 2020
Corrigendum to: "MAX to MYCN intracellular ratio drives the aggressive phenotype and clinical outcome of high risk neuroblastoma" [Biochim. Biophys. Acta, Gene Regul. Mech. 1861 (2018) 235-245]F Ferrucci, R Ciaccio, S Monticelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2001
Single nucleotide polymorphisms in the human reduced folate carrier: characterization of a high-frequency G/A variant at position 80 and transport properties of the His(27) and Arg(27) carriersJ R Whetstine, A J Gifford, T Witt, et al.
Oncogene|February 24, 2009
Patched1 deletion increases N-Myc protein stability as a mechanism of medulloblastoma initiation and progressionW D Thomas, J Chen, Y R Gao, et al.
American Journal of Epidemiology|March 1, 1994
Dietary glutathione intake and the risk of oral and pharyngeal cancerE W Flagg, R J Coates, D P Jones, et al.
Transfusion|January 1, 1980
Anti-Sdx: a "new" auto-agglutinin related to the Sda blood groupW L Marsh, C L Johnson, R Oyen, et al.
International Journal of Cancer|March 1, 1996
Involvement of MDR1 P-glycoprotein in multifactorial resistance to methotrexateM D Norris, D De Graaf, M Haber, et al.
British Journal of Cancer|July 14, 2005
The retinoid anticancer signal: mechanisms of target gene regulationT Liu, A Bohlken, S Kuljaca, et al.
Neurology|March 27, 2002
Neuropsychological and psychiatric sequelae of pallidotomy for PD: clinical trial findingsJ Green, W M McDonald, J L Vitek, et al.
Pageof 31

Showing results (271-280 of 303) with videos related to

Sort By:
Pageof 31
Neurology|November 13, 2002
Cognitive impairments in advanced PD without dementiaJ Green, W M McDonald, J L Vitek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2000
MYCN expression is not prognostic of adverse outcome in advanced-stage neuroblastoma with nonamplified MYCNS L Cohn, W B London, D Huang, et al.
Biochimica Et Biophysica Acta. Gene Regulatory Mechanisms|November 3, 2020
Corrigendum to: "MAX to MYCN intracellular ratio drives the aggressive phenotype and clinical outcome of high risk neuroblastoma" [Biochim. Biophys. Acta, Gene Regul. Mech. 1861 (2018) 235-245]F Ferrucci, R Ciaccio, S Monticelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2001
Single nucleotide polymorphisms in the human reduced folate carrier: characterization of a high-frequency G/A variant at position 80 and transport properties of the His(27) and Arg(27) carriersJ R Whetstine, A J Gifford, T Witt, et al.
Oncogene|February 24, 2009
Patched1 deletion increases N-Myc protein stability as a mechanism of medulloblastoma initiation and progressionW D Thomas, J Chen, Y R Gao, et al.
American Journal of Epidemiology|March 1, 1994
Dietary glutathione intake and the risk of oral and pharyngeal cancerE W Flagg, R J Coates, D P Jones, et al.
Transfusion|January 1, 1980
Anti-Sdx: a "new" auto-agglutinin related to the Sda blood groupW L Marsh, C L Johnson, R Oyen, et al.
International Journal of Cancer|March 1, 1996
Involvement of MDR1 P-glycoprotein in multifactorial resistance to methotrexateM D Norris, D De Graaf, M Haber, et al.
British Journal of Cancer|July 14, 2005
The retinoid anticancer signal: mechanisms of target gene regulationT Liu, A Bohlken, S Kuljaca, et al.
Neurology|March 27, 2002
Neuropsychological and psychiatric sequelae of pallidotomy for PD: clinical trial findingsJ Green, W M McDonald, J L Vitek, et al.
Pageof 31